Fisher & Paykel Demonstrates Humidified Nasal High Flow System for Delivering Respiratory Support at MEDICA 2021
Fisher & Paykel Healthcare (F&P; Auckland, New Zealand) demonstrated its Airvo 2 nasal high flow (NHF) system that is designed to deliver proven respiratory support at MEDICA 2021. More...18 Nov 2021
COVID-19 PCR and Antibody Tests Record Negative Result in People with ‘Immune Memory’, Reveals Study
An observational study which analyzed the immune responses in healthcare workers has found that some of them repeatedly tested negative for COVID-19 by PCR and antibody tests, but showed an increase in immune memory cells. More...13 Nov 2021
Use of Non-Invasive Breathing Support to Treat COVID-19 Does Not Increase Infection Risk, Finds Study
New research has found that the use of non-invasive breathing support to treat moderate to severe COVID-19 infection, isn’t linked to a heightened infection risk, as currently thought. More...09 Nov 2021
Identification of COVID Proteins Responsible for Damaging Blood Vessels to Help Develop Targeted Drugs for COVID-19
For the first time since the outbreak of COVID-19, researchers have been able to identify five of the 29 proteins which make up the SARS-CoV-2 virus that are responsible for damaging blood vessels. More...08 Nov 2021
In Other News
Delivering COVID-19 Vaccines via Suctioning Technique May Help Generate Higher Antibody Levels
Pfizer’s Novel COVID-19 Pill Cuts Risk of Hospitalization or Death by 90%
Merck and Ridgeback’s Oral COVID-19 Antiviral Medicine Receives First Authorization in the World
High-Energy X-Rays Emitted by Special Particle Accelerator Show Lung Vessels Altered by COVID-19
Portable Air Filters Effectively Remove SARS-CoV-2 Particles from Hospital Air in COVID-19 Surge Units
Pfizer-BioNTech COVID-19 Vaccine Becomes First to Receive FDA EUA in Children 5 Through 11 Years of Age
Potential New Treatment That Suppresses Replication of SARS-CoV-2 Could Be a Breakthrough in COVID-19 Therapy
Smartwatch-Based Algorithm Detects Early Signs of Viral Infections, Including COVID-19
Non-Invasive Breath Test Identifies COVID-19 Infection within 72 Hours of Onset of Respiratory Failure in Critically Ill Patients
Urinary Biomarkers Predict Severe Kidney Injury in Hospitalized COVID-19 Patients
Extrapulmonary CT Findings Predict In-Hospital Mortality in COVID-19
Testing for Specific Genetic Biomarkers Could Diagnose SARS-CoV-2 Infection and Predict COVID-19 Severity
D-Dimer Test Can Still Help Rule Out Pulmonary Embolisms in Hospitalized COVID-19 Patients
European Commission Identifies 10 Most Promising Treatments for COVID-19
AI Tool That Detect Anomalies in Medical Images Could Help Physicians Spot Onset of COVID-19 Pneumonia in X-Rays
BBQ Lighter, Combined with Microneedles, Sparks Breakthrough in COVID-19 Vaccine Delivery
New Algorithm for Rapid, Automated Diagnosis of COVID-19 from Chest CTs Overcomes RT-PCR Limitations
AI Tool Pairs Protein Pathways with Drug Side Effects and Patient Comorbidities to Suggest Targeted COVID-19 Treatments
Radiologists Accurately Differentiate Between COVID-19 and Other Atypical Pneumonias on Chest CT, Finds Study
Cell Fitness Status Detected from Nasal Swab Test Could Accurately Predict Hospitalization or Death in COVID-19 Patients
High-Dose of Inexpensive and Globally Available Blood Thinner Reduces Risk of Death for Moderately Ill COVID-19 Patients
Assessing Stiffness of Arteries Could Help Identify Patients Most at Risk of Dying From COVID-19
Newly Identified Highly Potent Monoclonal Antibody Against SARS-CoV-2 Neutralizes All COVID-19 Variants of Concern